Zacks Investment Research on MSN
Here is what to know beyond why Novavax, Inc. (NVAX) is a trending stock
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
This stock could be a wealth destroyer in the next five years.
The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...
It was 2020 and Maryland biotech Novavax was thinking big. It had a plan to become a COVID vaccine powerhouse, with enough manufacturing capacity to supply the U.S. all by itself, as its executives ...
On Oct. 3, the Food and Drug Administration (FDA) authorized the updated COVID-19 vaccine by Novavax for people ages 12 and older. The Centers for Disease Control and Prevention and its advisory panel ...
Novavax (NVAX-0.94%) stock is up around 3,500% so far this year. And that's after a significant recent decline. Earlier this month, shares of Novavax were up nearly 4,400% year to date. These ...
Shares of Novavax fell more than 25% in after-hours trading Tuesday, following a dismal fourth quarter earnings report and a warning from the Covid vaccine maker that uncertainty over future funding ...
Novavax is used to prevent COVID-19 in adults and in children ages 12 years and older. The vaccine is given as an injection into the muscle of your upper arm. The active ingredient in Novavax is ...
The Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization, paving the way for a new fourth option for the 10% of American adults who have yet to receive at ...
Shares of COVID-19 vaccine maker Novavax cratered Tuesday as the U.S. biotech company slashed its sales forecast due to a slump in demand for its shots. The company's stock dived 31% after it cut its ...
How the United States' potential fourth vaccine stacks up against existing ones. Maryland-based biotech company Novavax said Monday that its COVID-19 vaccine was shown to be highly effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results